Cryoport Consensus Price Target Raised 10.69% to $21.95

The average one-year price target for Cryoport (NASDAQCM:CYRX) (DB:CKX) has been revised to $21.95 / share. This is an increase of 10.69% from the prior estimate of $19.83 dated October 30, 2026. These figures represent aggregate analyst targets compiled as of November 6, 2026, and do not constitute a recommendation by Fintel.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $16.87 to a high of $29.40 / share. The average price target represents an increase of 7.30% from the latest reported closing price of $20.46 / share as of November 9, 2026. The median target increased to $21.42 from $20.40, representing an absolute median change of $1.02. The target range widened, with the current target range width at $12.53 compared to the prior width of $12.15, a change of +3.15%.

Looking at target history, the mean target was $21.95 on November 10, 2026, compared to $19.83 on November 2, 2026, and October 23, 2026, and $19.72 on October 3, 2026. The observed twelve-month high mean target is $21.95, recorded on November 10, 2026, while the observed twelve-month low mean target is $13.49, recorded on February 25, 2026. This represents a target change of +40.67% since the 90-day baseline date of August 4, 2026. In terms of price performance, Cryoport's share price changed by +26.10% over one week from a baseline close of $16.22 on November 2, 2026, and by +17.93% over one month from a baseline close of $17.35 on October 9, 2026.

Cryoport operates in the temperature-controlled logistics industry, providing solutions to support the life sciences and biopharmaceutical sectors. The company reported its latest earnings on November 5, 2026, with an actual EPS of -0.25 compared to an estimated EPS of -0.1799. Actual revenue was $50,220,000.00, which was a +0.83% surprise compared to the estimated revenue of $49,805,070.00.

Recent analyst actions include Keybanc maintaining an Overweight rating on November 6, 2026, and Needham maintaining a Buy rating on the same date. BTIG also maintained a Buy rating on October 13, 2026. The recommendation trend for the period of November 1, 2026, shows a total of 15 recommendations, consisting of 6 strong buy, 7 buy, and 2 hold ratings, which is unchanged from the October 1, 2026, period.

Within the GICS Passenger Airlines sub-industry, which covers 24 companies, 8 companies raised their targets, 5 lowered, and 10 remained unchanged, with a median revision percent of 0.00% and a median implied change percent of +24.82%.

The peer group showed mixed target revisions, with Cencora and FedEx showing positive implied changes.

Take Fintel with you. Download the Fintel app from the App Store or Google Play.

This story originally appeared on Fintel.